Informing People-Centered Target Product Profiles for TB Diagnostics: A Multi-Country Qualitative Study
María del Mar Castro(Centro Internacional de Entrenamiento e Investigaciones Medicas), Ha Phan(The University of Texas at San Antonio Health Science Center), Hien Nam Le(Center for Promotion of Advancement of Society), Claudia M. Denkinger(Heidelberg University), Devasahayam Jesudas Christopher, Victoria Dalay(De La Salle University – Dasmariñas), William Worodria(Mulago Hospital), Nora West(University of California, San Francisco), Annet Nakaweesa(World Health Organization - Uganda), Andrew D. Kerkhoff(San Francisco General Hospital), Adithya Cattamanchi(University of California, San Francisco), Grant Theron(South African Medical Research Council), Elisabeth Mamani-Mategula(Heidelberg University), Rouxjeane Venter(National Research Foundation), K. M. Anil Kumar(Christian Medical College, Vellore), Kinari Shah(San Francisco General Hospital), Charles Yu(La Salle University), Payam Nahid(University of California, San Francisco)
Cited by 3
Related Papers
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
|European Respiratory Journal|2014|532